Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Azemat Jamshidi‐Parsian

Federal Grant PI

Role not yet determined Is this you? Add your title

Also affiliated: University of Louisville (2003–2024); University of Arkansas Medical Center (2015–2023)

17 h-index 59 pubs 1,570 cited

  • Humans
  • Animals
  • Mice
  • Cell Line, Tumor
  • Apoptosis
  • Lung Neoplasms
  • Female
  • Melanoma
  • Neoplastic Cells, Circulating
  • Neoplasms
  • Hyperthermia, Induced
  • Gold
  • Radiation Tolerance
  • Male
  • Disease Models, Animal

Biography and Research Information

OverviewAI-generated summary

Azemat Jamshidi‐Parsian's research focuses on cancer biology and treatment, with a particular emphasis on lung cancer and melanoma. Their work investigates the role of metabolic pathways, such as glutamine metabolism, in influencing tumor cell sensitivity to radiation therapy. Studies have explored how manipulating these pathways, for example, using glutaminase inhibitors, can enhance therapeutic outcomes in preclinical models, including lung tumor xenografts in mice.

Further research extends to advanced diagnostic techniques and therapeutic strategies. This includes the development and application of liquid biopsy platforms for the photoacoustic detection of circulating tumor cells in melanoma patients. Additionally, Jamshidi‐Parsian has investigated the impact of microenvironmental factors like hypoxia and exosomes on glioblastoma cells, and explored the potential of combining mild hyperthermia with radiation therapy. Their work also examines the interplay between radiotherapy, immunotherapy, and the tumor microenvironment to elicit anti-tumor immunity.

Jamshidi‐Parsian has received federal funding from the NIH/National Cancer Institute for research focused on improving cellular immunotherapy during dysbiosis. They lead a research group and collaborate with several colleagues at the University of Arkansas for Medical Sciences, including Robert Griffin and Samir V. Jenkins, with whom they have co-authored numerous publications. Their scholarship metrics include an h-index of 17, with over 1,570 citations across 57 publications.

Metrics

  • h-index: 17
  • Publications: 59
  • Citations: 1,570

Selected Publications

  • Gene Expression Profile of Gm20594 and Hapln1 in Mouse Cardiac Muscle Exposed to Microgravity and Space-like Chronic Low-Dose Radiation (2025)
    PubMed DOI OpenAlex
  • Musculoskeletal miRNA profiling after exposure to simulated space stressors in mice (2025)
    PubMed DOI OpenAlex
  • Pancreatic cancer extracellular vesicles stimulate Schwann cell activation and perineural invasion in vitro via IL-8/CCL2 (2025)
    In vitro models 9 citations DOI OpenAlex
  • Abstract B026: Pancreatic tumor extracellular vesicles induce perineural invasion in vitro via IL- 8/CCL2 (2024)
    Cancer Research 1 citation DOI OpenAlex
  • CB-839 induces reversible dormancy in lung tumor-cells (2024)
    European Journal of Pharmacology 8 citations DOI OpenAlex
  • Pancreatic Cancer Extracellular Vesicles Stimulate Schwann Cell Activation and Perineural Invasion in Vitro Via Il-8/Ccl2 (2024)
    SSRN Electronic Journal DOI OpenAlex
  • Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A (2024)
    Cancer Research DOI OpenAlex
  • Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials (2023)
    ACS Applied Materials & Interfaces 3 citations DOI OpenAlex
  • Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells (2023)
    International Journal of Molecular Sciences 12 citations DOI OpenAlex
  • Exploiting nanopore sequencing for characterization and grading of IDH‐mutant gliomas (2023)
    Brain Pathology 13 citations DOI OpenAlex
  • Pancreatic Tumor-Derived Extracellular Vesicles Stimulate Schwann Cell Phenotype Indicative of Perineural Invasion via IL-8 Signaling (2023)
    bioRxiv (Cold Spring Harbor Laboratory) 4 citations DOI OpenAlex
  • Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes (2023)
    Biochemistry and Biophysics Reports 1 citation DOI OpenAlex
  • Proteomic Analysis of Transcription Factors Involved in the Alteration of Ischemic Mouse Heart as Modulated by MSC Exosomes (2023)
    SSRN Electronic Journal 1 citation DOI OpenAlex
  • Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022)
    International Journal of Molecular Sciences 8 citations DOI OpenAlex
  • Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022)
    Preprints.org 4 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $348,182 total

NIH Contact PI Sep 2021 - Aug 2026

Improvement of cellular immunotherapy during dysbiosis- Resubmission

National Cancer Institute $348,182 R01

Collaboration Network

152 Collaborators 29 Institutions 5 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics